期刊文献+
共找到2,810篇文章
< 1 2 141 >
每页显示 20 50 100
Mental health in the virtual world:Challenges and opportunities in the metaverse era
1
作者 Yolanda López del Hoyo Matilde Elices Javier Garcia-Campayo 《World Journal of Clinical Cases》 SCIE 2024年第17期2939-2945,共7页
Current rates of mental illness are worrisome.Mental illness mainly affects females and younger age groups.The use of the internet to deliver mental health care has been growing since 2020 and includes the implementat... Current rates of mental illness are worrisome.Mental illness mainly affects females and younger age groups.The use of the internet to deliver mental health care has been growing since 2020 and includes the implementation of novel mental health treatments using virtual reality,augmented reality,and artificial intelligence.A new three dimensional digital environment,known as the metaverse,has emerged as the next version of the Internet.Artificial intelligence,augmented reality,and virtual reality will create fully immersive,experiential,and interactive online environments in the metaverse.People will use a unique avatar to do anything they do in their“real”lives,including seeking and receiving mental health care.In this opinion review,we reflect on how the metaverse could reshape how we deliver mental health treatment,its opportunities,and its challenges. 展开更多
关键词 Metaverse Virtual world Artificial intelligence Mental health Virtual reality Augmented reality TECHNOLOGY
下载PDF
用于国家监管体系评估的WHO全球基准工具介绍及其应用进展
2
作者 徐宏山 李玉华 《中国药事》 CAS 2024年第1期1-10,共10页
目的:对世界卫生组织(World Health Organization,WHO)用于国家监管体系(National Regulatory Authorities,NRA)评估的全球基准工具(Global Benchmarking Tool,GBT)及基准流程进行介绍和深入研究,旨在帮助相关人员进一步了解WHO关于NRA... 目的:对世界卫生组织(World Health Organization,WHO)用于国家监管体系(National Regulatory Authorities,NRA)评估的全球基准工具(Global Benchmarking Tool,GBT)及基准流程进行介绍和深入研究,旨在帮助相关人员进一步了解WHO关于NRA评估的新的具体要求,进一步推动医疗产品检验检测和疫苗批签发管理水平提高。方法:介绍GBT框架,对GBT 9大板块进行分析汇总,研究WHO采用GBT进行NRA评估的流程和应用进展以及对我国的启示。结果与结论:GBT针对国家监管体系9大职能板块分别设置一系列指标和268个亚指标进行评估,并引入4级成熟度级别(Maturity Level,ML)的概念;正式基准过程包括提交意向书、对意向书评估、就评估范围和路线图达成协议、正式评估、宣布决定和列名等5个步骤;截至2022年10月,WHO宣布共有12个国家通过了以GBT为基准的NRA评估。我国疫苗NRA评估已达到ML3水平,但仍需深入改进,向ML4水平继续努力。 展开更多
关键词 疫苗 世界卫生组织 国家监管体系 全球基准工具 NRA评估
下载PDF
Development of methods of male contraception: impact of the World Health Organization Task Force 被引量:7
3
作者 Geoffrey M.H.Waites Sc.D. 《Asian Journal of Andrology》 SCIE CAS CSCD 2003年第3期202-202,共1页
Objective: To give an historical record of the research of the World Health Organization (WHO) Task Force to develop methods of male contraception; to examine the social, political, medical, pharmaceutical, funding, a... Objective: To give an historical record of the research of the World Health Organization (WHO) Task Force to develop methods of male contraception; to examine the social, political, medical, pharmaceutical, funding, and other factors that influenced progress; and to suggest reasons why such methods are only now becoming available. Design: Review of basic and clinical research over 30 years. Setting: Task force of a multinational agency and collaborating agencies. Conclusion(s): Through the involvement of many international scientists, the WHO Task Force has uniquely contributed to the exploratory phases of the research in male contraception and by its multicenter contraceptive efficacy studies has accelerated progress towards the ideal hormonal method. Despite an adverse climate involving social and political attitudes, funding constraints, and pharmaceutical industry hesitations, WHO formed coalitions with governments and international agencies to sustain research with results that apply to men in culturally diverse populations and thereby to influence activities across the whole range of global reproductive health and family planning. 展开更多
关键词 world health organization male contraception clinical trials social factors reproductive health
下载PDF
Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization 被引量:5
4
作者 Amin Talebi Bezmin Abadi 《World Journal of Gastroenterology》 SCIE CAS 2017年第35期6379-6384,共6页
Due to the increasing prevalence of clarithromycin resistance, future of management of Helicobacter pylori(H. pylori) infections need to be recognized. To now, clarithromycin was the best effective, well-tolerated and... Due to the increasing prevalence of clarithromycin resistance, future of management of Helicobacter pylori(H. pylori) infections need to be recognized. To now, clarithromycin was the best effective, well-tolerated and safe antibiotic used in treatment of the bacterium, but, increasing trend of resistance reduced efficacy of recommended regimens. Indeed, gastroenterologists are mostly unable to start appropriate therapyaccording to the sensitivity profile-due to the certain difficulties in routine H. pylori culture procedure and being time consuming method. This announcement by World Health Organization(WHO) was an onset to reconsider current challenging dilemma about H. pylori clarithromycin resistant isolates. Therefore, investigating of various factors affecting this nomination by WHO is highly welcomed. In fact, WHO enumerated more than 16 pathogens which seriously threats human life and public health, thus better management or effective guidelines are necessary. Here for the first time, we nominated this phenomenon as ‘‘gastroenterologist's persistence'' which should be equally investigated as antibiotic resistance. The ability of gastroenterologists to win the game against H. pylori infections is highly influenced by their collaboration with diagnostic laboratories to apply susceptibility patterns before any prescription. In conclusion, closer collaboration between two important partners(gastroenterologists and microbiologists) in management of H. pylori infection may hopefully trigger an era to remedy current crisis in clarithromycin resistance, a later gastric cancer can be practically preventable. 展开更多
关键词 RESISTANCE CLARITHROMYCIN HELICOBACTER PYLORI world health organization
下载PDF
Simple approach for the histomolecular diagnosis of central nervous system gliomas based on 2021 World Health Organization Classification 被引量:2
5
作者 Maher Kurdi Rana H Moshref +4 位作者 Yousef Katib Eyad Faizo Ahmed A Najjar Basem Bahakeem Ahmed KBamaga 《World Journal of Clinical Oncology》 CAS 2022年第7期567-576,共10页
The classification of central nervous system(CNS)glioma went through a sequence of developments,between 2006 and 2021,started with only histological approach then has been aided with a major emphasis on molecular sign... The classification of central nervous system(CNS)glioma went through a sequence of developments,between 2006 and 2021,started with only histological approach then has been aided with a major emphasis on molecular signatures in the 4^(th) and 5^(th) editions of the World Health Organization(WHO).The recent reformation in the 5th edition of the WHO classification has focused more on the molecularly defined entities with better characterized natural histories as well as new tumor types and subtypes in the adult and pediatric populations.These new subclassified entities have been incorporated in the 5^(th) edition after the continuous exploration of new genomic,epigenomic and transcriptomic discovery.Indeed,the current guidelines of 2021 WHO classification of CNS tumors and European Association of Neuro-Oncology(EANO)exploited the molecular signatures in the diagnostic approach of CNS gliomas.Our current review presents a practical diagnostic approach for diffuse CNS gliomas and circumscribed astrocytomas using histomolecular criteria adopted by the recent WHO classification.We also describe the treatment strategies for these tumors based on EANO guidelines. 展开更多
关键词 Central Nervous System glioma Classification world health organization 2021 European Association of Neuro-Oncology guidelines
下载PDF
Mental health promotion for elderly populations in World Health Organization South-East Asia Region:Needs and resource gaps 被引量:1
6
作者 Nisha Mani Pandey Rakesh Kumar Tripathi +2 位作者 Sujita Kumar Kar K L Vidya Nitika Singh 《World Journal of Psychiatry》 SCIE 2022年第1期117-127,共11页
The accelerated population growth of the elderly(individuals aged 60 years or more)across the globe has many indications,including changes in demography,health,the psycho-social milieu,and economic security.This trans... The accelerated population growth of the elderly(individuals aged 60 years or more)across the globe has many indications,including changes in demography,health,the psycho-social milieu,and economic security.This transition has given rise to varied challenges;significant changes have been observed in regard to developing strategies for health care systems across the globe.The World Health Organization(WHO)is also engaging in initiatives and mediating processes.Furthermore,advocacy is being conducted regarding a shift toward the salutogenic model from the pathogenic model.The concept behind this move was to shift from disablement to enablement and from illness to wellness,with the notion of mental health promotion(MHP)being promoted.This article attempts to discuss the MHP of elderly individuals,with special reference to the need to disseminate knowledge and awareness in the community by utilizing the resources of the health sector available in the WHO South-East Asia Region countries.We have tried to present the current knowledge gap by exploring the existing infrastructure,human resources,and financial resources.There is much to do to promote the mental health of the elderly,but inadequate facilities are available.Based on available resources,a roadmap for MHP in elderly individuals is discussed. 展开更多
关键词 Mental health promotion ELDERLY Mental healthcare needs Resource gaps world health organization
下载PDF
2023年版WHO基本药物示范目录特点分析及启示
7
作者 韩雨倍 刘文臣 +2 位作者 陈琛 杨才君 方宇 《中国卫生政策研究》 CSCD 北大核心 2024年第2期53-58,共6页
对2023年版世界卫生组织的基本药物示范目录(第23版)与儿童基本药物示范目录(第9版)进行分析,首先梳理目录调整的工作流程与递交申请所需的材料;接着归纳新版目录的调整依据和特点,目录内的药物数量创历史新高、广泛纳入创新药、审慎遴... 对2023年版世界卫生组织的基本药物示范目录(第23版)与儿童基本药物示范目录(第9版)进行分析,首先梳理目录调整的工作流程与递交申请所需的材料;接着归纳新版目录的调整依据和特点,目录内的药物数量创历史新高、广泛纳入创新药、审慎遴选儿童药、重视临床获益证据与公共卫生可负担性。建议参考WHO经验,结合国情尽快对我国基本药物目录进行更新,注意基药目录与医保目录的区别与联系,做好目录衔接,满足基本用药需求,确保药品可及性,优化卫生资源配置。 展开更多
关键词 世界卫生组织 基本药物示范目录 遴选程序 循证依据 医保目录
下载PDF
World Flu Day: Protecting Health, Keeping away from Flu Troubles
8
作者 CUI Yun Shang 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2023年第12期1196-1196,共1页
November 1,2023 marks the 6th"World Flu Day".The theme is"Preventing Influenza,Protecting Health"in this year.According to data from the World Health Organization,influenza infects approximately 5%... November 1,2023 marks the 6th"World Flu Day".The theme is"Preventing Influenza,Protecting Health"in this year.According to data from the World Health Organization,influenza infects approximately 5%-10%of adults and 20%-30%of children worldwide each year,resulting in up to 5million severe cases and 650,000 deaths.A recent study showed that about 88,000 people in China died from respiratory diseases caused by influenza each year,accounting for 8.2%of total respiratory disease deaths,making influenza a serious threat to public health. 展开更多
关键词 world health Protectin
下载PDF
Assessment of Medicines Cold Chain Storage Conformity with the World Health Organization Requirements in Health Facilities in Tanzania 被引量:1
9
作者 Siya Ringo Veronica Mugoyela +1 位作者 Eliangiringa Kaale Joseph Sempombe 《Pharmacology & Pharmacy》 2017年第10期325-338,共14页
A descriptive study on assessment of medicines cold chain storage conformity with World Health Organization (WHO) requirements in public health facilities was carried out in Dar es Salaam and Dodoma regions. Storage c... A descriptive study on assessment of medicines cold chain storage conformity with World Health Organization (WHO) requirements in public health facilities was carried out in Dar es Salaam and Dodoma regions. Storage conformity in selected health facilities was assessed by monitoring temperature using temperature data loggers mounted in the refrigerators for a period of 30 days. Results indicated almost half of the health facilities 48.5% visited, did not significantly (P = 0.031) comply with storage temperature (+2°C to +8°C) as per WHO requirement because all recorded Mean Kinetic temperature (MKT) > 8°C. In rural areas, 59.2% of visited health facilities adhered to the WHO recommended storage temperature while in urban areas only 31.6% complied. The study has established electricity failure in urban and lack of gas in rural areas coupled with absence of contingency plan as major challenges to WHO temperature conformity in storage of cold chain medicines in health facilities in Tanzania. 展开更多
关键词 TEMPERATURE Monitoring Cold CHAIN MEDICINES Mean KINETIC TEMPERATURE world health organization Standards
下载PDF
基于WHO疫苗国家监管体系评估等标准和指南要求对OOS分析工作的思考
10
作者 张姮婕 刘雅丹 +8 位作者 马晶 李炎 蒋佳兴 秦力 林涛 杨蕾 崔学文 徐苗 项新华 《中国食品药品监管》 2024年第5期70-77,共8页
随着我国通过世界卫生组织(WHO)疫苗国家监管体系(NRA)评估,以及疫苗批签发能力建设的不断推进,越来越多的省级药品检验机构陆续加入疫苗批签发体系。本文基于WHO疫苗NRA评估要求,结合国际上疫苗相关主要法规或指南,探讨疫苗及药品检验... 随着我国通过世界卫生组织(WHO)疫苗国家监管体系(NRA)评估,以及疫苗批签发能力建设的不断推进,越来越多的省级药品检验机构陆续加入疫苗批签发体系。本文基于WHO疫苗NRA评估要求,结合国际上疫苗相关主要法规或指南,探讨疫苗及药品检验结果超标(OOS)分析工作中需要重点关注和易混淆的内容,以期对相关人员开展工作有所启示。 展开更多
关键词 疫苗 世界卫生组织 国家监管体系 检验结果超标 法规 指南
下载PDF
2022年WHO头颈部肿瘤分类(第5版)的解读:口腔和舌体上皮性肿瘤
11
作者 李金薇 沙桐 +3 位作者 郑凯娟 聂孟冬 关苇杭 史册 《口腔颌面外科杂志》 CAS 2024年第2期81-86,共6页
2022年3月,世界卫生组织(World Health Organization,WHO)发布了第5版《头颈部肿瘤分类》。第5版的口腔和舌体肿瘤部分中,上皮性肿瘤相较于2017年的第4版作出了一些修改,其中包括将口腔潜在恶性疾病(oral potentially malignant disorde... 2022年3月,世界卫生组织(World Health Organization,WHO)发布了第5版《头颈部肿瘤分类》。第5版的口腔和舌体肿瘤部分中,上皮性肿瘤相较于2017年的第4版作出了一些修改,其中包括将口腔潜在恶性疾病(oral potentially malignant disorders,OPMD)和口腔上皮异常增生(oral epithelial dysplasia,OED)作了分开阐述,并详细讨论了黏膜下纤维性变(submucousfibrosis,SF)和人乳头瘤病毒(human papillomavirus,HPV)相关性口腔上皮异常增生(HPV-associated oral epithelial dysplasia,HPVOED);在鳞状细胞癌(squamous cell carcinoma,SCC)部分,介绍了穿掘性癌(carcinoma cuniculatum,CC)和疣状癌(verrucous carcinoma,VC),并阐述了其特有的临床和组织学特征。本文总结了自2017年来口腔和舌体的上皮性肿瘤相关内容在临床、组织学和分子学研究中的最新进展。 展开更多
关键词 世界卫生组织 口腔和舌体肿瘤 非肿瘤性病变 上皮性肿瘤
下载PDF
Classificatory updates in verrucous and cuniculatum carcinomas:Insights from the 5^(th) edition of WHO-IARC head and neck tumor classification
12
作者 Felipe Martins Silveira Lauren Frenzel Schuch Ronell Bologna-Molina 《World Journal of Clinical Oncology》 2024年第4期464-467,共4页
The International Agency for Research on Cancer(IARC)and World Health Organization(WHO)collaboratively produce the'WHO Blue Books'essential tools standardizing the diagnostic process for human cancers.Regular ... The International Agency for Research on Cancer(IARC)and World Health Organization(WHO)collaboratively produce the'WHO Blue Books'essential tools standardizing the diagnostic process for human cancers.Regular updates in this classification accommodate emerging molecular discoveries,advances in immunohistochemical techniques,and evolving clinical insights.The 5th edition of the WHO/IARC classification of head and neck tumors refines the'Oral Cavity and Mobile Tongue'chapter,including sections for non-neoplastic lesions,epithelial tumors,and tumors of uncertain histogenesis.Notably,the epithelial tumors section is rearranged by tumor behavior,starting with benign squamous papillomas and progressing through potentially malignant oral disorders to oral squamous cell carcinoma(OSCC).The section on OSCC reflects recent information on epidemiology,pathogenesis,and histological prognostic factors.Noteworthy is the specific categorization of verrucous carcinoma(VC)and carcinoma cuniculatum(CC),both associated with the oral cavity and distinct in clinical and histologic characteristics.This classification adjustment emphasizes the oral cavity as their predominant site in the head and neck.Designating specific sections for VC and CC aims to provide comprehensive insights into these unique subtypes,elucidating their clinical features,distinct histological characteristics,prevalence,significance,and clinical relevance.By categorizing these subtypes into specific sections,the 5th edition of the WHO classification aims to provide a more nuanced and detailed account,enhancing our understanding of these specific variants within the broader spectrum of head and neck tumors. 展开更多
关键词 world health organization Squamous cell carcinoma of head and neck Verrucous carcinoma Mouth neoplasms
下载PDF
Assessing Barriers to Mental Healthcare Interventions for Deaf People in Ghana
13
作者 Wisdom Kwadwo Mprah Juventus Duorinaah +1 位作者 Lyla Adwan-Kamara Rebecca Tawiah 《Journal of Biosciences and Medicines》 2024年第1期29-51,共23页
While mental health issues are increasingly gaining attention in Ghana, little is known about the situation among deaf people. This study assessed the mental health care needs of deaf people in Ghana. A descriptive de... While mental health issues are increasingly gaining attention in Ghana, little is known about the situation among deaf people. This study assessed the mental health care needs of deaf people in Ghana. A descriptive design, consisting of interviews and focus group discussions, was used to collect data from 97 participants. Findings indicated that participants had limited knowledge on mental health issues. Mental health stigma, inaccessible mental health information and exclusion from mental health programmes were the major barriers hindering access to mental health care services. This study bridges the knowledge gap and provides evidence for the implementation of deaf-friendly services. 展开更多
关键词 ACCESS Barriers Deaf People Mental health CAREGIVERS Civil Society organizations
下载PDF
The World Health Organization Surgical Safety Checklist Improves Post-Operative Outcomes: A Meta-Analysis and Systematic Review
14
作者 Christine S. M. Lau Ronald S. Chamberlain 《Surgical Science》 2016年第4期206-217,共12页
Background: The incidence of in-hospital adverse events is about 10%, with a majority of these related to surgery, and nearly half considered preventable events. In attempts to improve patient safety, the World Health... Background: The incidence of in-hospital adverse events is about 10%, with a majority of these related to surgery, and nearly half considered preventable events. In attempts to improve patient safety, the World Health Organization (WHO) developed a checklist to be used at critical perioperative moments. This meta-analysis examines the impact of the WHO surgical safety checklist (SSC) on various patient outcomes. Methods: A comprehensive search of all published studies assessing the use of the WHO SSC in patients undergoing surgery was conducted. Studies using the WHO SSC in any surgical setting, with pre-implementation and post-implementation outcome data were included. The incidence of patient outcomes (total complications, surgical site infections, unplanned return to the operating room (OR) within 30 days, and overall mortality) and adherence to safety measures were analyzed. Results: 10 studies involving 51,125 patients (27,490 prior to implementation and 23,635 after implementation of the WHO SSC) were analyzed. The implementation of the WHO SSC significantly reduced the risk of total complications by 37.9%, surgical site infections by 45.5%, unplanned return to OR by 32.1%, and mortality by 15.3%. Increased adherence to safety measures including airway evaluation, use of pulse oximetry, prophylactic antibiotics when necessary, confirmation of patient name and surgical site, and sponge count was also observed. Conclusions: The use of the WHO SSC is associated with a significant reduction in post-operative complication rates and mortality. The WHO SSC is a valuable tool that should be universally implemented in all surgical centers and utilized in all surgical patients. 展开更多
关键词 world health organization Surgical Checklist Safety Checklist Patient Safety
下载PDF
将WHO《心理健康差距干预指南》应用于中国全科医学服务:一项德尔菲研究
15
作者 Kendall Searle Grant Blashki +5 位作者 Ritsuko Kakuma 杨辉 吕淑荣 李宝琪 肖莹莹 Harry Minas 《中国全科医学》 北大核心 2024年第1期15-26,共12页
背景中国全科医生越来越期望能够识别和预防抑郁障碍,但其接受的心理健康培训有限,社区卫生服务中心(CHCs)也缺乏针对抑郁障碍的诊断和服务规范。WHO《心理健康差距干预指南》第2版(mhGAP-IG.v2)是为非心理健康专业人员提供的决策支持工... 背景中国全科医生越来越期望能够识别和预防抑郁障碍,但其接受的心理健康培训有限,社区卫生服务中心(CHCs)也缺乏针对抑郁障碍的诊断和服务规范。WHO《心理健康差距干预指南》第2版(mhGAP-IG.v2)是为非心理健康专业人员提供的决策支持工具,可用于评估、管理、随访精神障碍、神经疾病及物质使用障碍患者。鉴于mhGAP-IG.v2的通用性,其在中国的应用应根据抑郁障碍在不同文化下的差异性和中国心理健康系统特点进行调整。方法开展两轮基于网络的德尔菲(Delphi)调查。邀请来自深圳市的全科医生小组对mhGAP-IG.v2中涉及抑郁障碍的199条表述进行五分制的赞同程度打分,即“如要把该表述用在深圳市,是否赞同调整其内容和结构”。如果>80%的全科医生“有些/肯定赞同”调整某表述,则视为全科医生对调整该表述达成共识;如果>80%的全科医生“有些/肯定不赞同”调整某表述,则视为全科医生对不调整该表述达成共识。结果全科医生对79%的表述达成了需要调整的共识,平均得分为4.26分,即全科医生“有些赞同”对mh GAP-IG.v2中涉及抑郁障碍的相关表述进行调整。具体调整建议包括:抑郁评估方法应考虑更广泛的抑郁症状,并考虑病情的发展阶段;增加抑郁筛查工具的使用指南;明确全科医生的作用,以及家庭参与和跨部门服务的转诊途径;药物治疗建议应与中国用药规范保持一致;指南所有章节要强调预防自杀;情境化健康教育;强调“以人为本”的服务方法。全科医生认为,应维持mhGAP-IG.v2中对经历抑郁发作的双相障碍患者的诊断和治疗建议。结论对mhGAP-IG.v2抑郁部分的调整研究反映出对指南的评估应考虑文化和国情背景,包括中国特色的初级卫生保健系统、健康优先领域、治疗可得性,以及多样化的社会心理教育需要。调整后的mhGAP-IG.v2可以给中国全科医学教育和全科医疗服务提供参考,也可以为其他国家的非精神病学专业人员开展心理健康服务提供有益借鉴。 展开更多
关键词 抑郁障碍 心理健康差距干预指南 德尔菲 调整 概念化 初级保健 跨部门服务 世界卫生组织 中国 深圳
下载PDF
中国体育学术英文期刊的画像分析:以Journal of Sport and Health Science为例
16
作者 朱建明 施丹丹 《福建体育科技》 2024年第3期60-66,75,共8页
Journal of Sport and Health Science《运动与健康科学》(英文版),简称JSHS,是我国内地地区第一本英文体育学术期刊,深入分析和全面认识JSHS的期刊画像特征,对我国体育学术英文期刊国际化发展实践和建设世界一流期刊均具有重要现实意... Journal of Sport and Health Science《运动与健康科学》(英文版),简称JSHS,是我国内地地区第一本英文体育学术期刊,深入分析和全面认识JSHS的期刊画像特征,对我国体育学术英文期刊国际化发展实践和建设世界一流期刊均具有重要现实意义。采集Web of Science数据库中2012-2022年755篇JSHS论文,基于科学计量的方法,系统挖掘了JSHS在时间产出、作者合作、机构分布、刊文热点与趋势等特征,还从影响因子、即年指标、被引半衰期等指标,对标对表British Journal of Sports Medicine(简称BJSM,英国运动医学杂志)进行深入分析。研究发现:JSHS作为新创的体育科学期刊和我国建设世界一流期刊的代表,总体发展势头良好。年载文量稳步增长,期刊影响因子、论文影响力显著提升。论文高产机构来自上海体育学院、北卡罗莱纳大学、卡尔加里大学等,高产作者有Walter Herzog、刘宇、于冰、陈佩杰等,作者队伍越来越壮大,且呈团队合作趋势。JSHS在不断发展中形成6大主题群,包括儿童青少年运动与健康促进、老年人群运动与健康、运动表现分析、运动损伤、运动与疾病风险以及运动与认知功能。对标对表BJSM分析,JSHS在出版周期、年发文量、论文影响力等方面亟需提升。 展开更多
关键词 Journal of Sport and health Science 体育学术期刊 世界一流 期刊画像 科学计量
下载PDF
2022年WHO全球结核病报告:全球与中国关键数据分析 被引量:52
17
作者 宋敏 陆普选 +2 位作者 方伟军 韩远远 梁瑞云 《新发传染病电子杂志》 2023年第1期87-92,共6页
结核病是仅次于新型冠状病毒感染(COVID-19)的第二大传染性疾病杀手,也是全球第十三大死亡原因。《2022年全球结核病报告》(以下简称2022年报告)显示:2021年,全世界估计新增1060万结核病患者,其中600万人是成年男性,340万人是成年女性,... 结核病是仅次于新型冠状病毒感染(COVID-19)的第二大传染性疾病杀手,也是全球第十三大死亡原因。《2022年全球结核病报告》(以下简称2022年报告)显示:2021年,全世界估计新增1060万结核病患者,其中600万人是成年男性,340万人是成年女性,120万人是儿童。HIV感染者占总数的6.7%。新诊断的患有结核病并向各国政府报告的病例数从2020年的580万恢复到2021年的640万,仍有约420万未被诊断或未被报告。结核病发病率上升,死亡病例数有所增加。2021年,由结核病引起的死亡病例数估计是由HIV感染引起的死亡病例数的两倍多。2021年新增45万例利福平耐药结核病(RR-TB)患者,明显高于2020年,然而耐药结核病的治疗覆盖率及治疗成功率依然较低。2022年报告提示COVID-19大流行在全球结核病防治工作中的影响仍在继续。2022年报告呼吁多部门加倍努力,增加对基本结核病服务和研究的资助,减轻和扭转COVID-19大流行对结核病防治服务的负面影响,以实现终结结核病的目标和拯救生命。 展开更多
关键词 世界卫生组织 结核病 报告 新型冠状病毒感染 艾滋病
下载PDF
基于WHO-FICs作业治疗改善脑卒中上肢功能效果的系统综述 被引量:1
18
作者 徐悦莹 郑洁皎 +2 位作者 高文 丁建伟 陈茜 《中国康复理论与实践》 CSCD 北大核心 2023年第2期140-150,共11页
目的基于世界卫生组织国际分类家族(WHO-FICs)构建作业治疗改善脑卒中上肢功能的PICO架构,并分析主要作业疗法改善脑卒中患者上肢功能的效果。方法运用WHO-FICs框架,检索Web of Science、PubMed、CNKI、SinoMed等数据库,收集建库至2022... 目的基于世界卫生组织国际分类家族(WHO-FICs)构建作业治疗改善脑卒中上肢功能的PICO架构,并分析主要作业疗法改善脑卒中患者上肢功能的效果。方法运用WHO-FICs框架,检索Web of Science、PubMed、CNKI、SinoMed等数据库,收集建库至2022年10月关于作业治疗干预脑卒中上肢功能的相关文献,并进行系统综述。结果最终纳入10项随机对照试验,382例参与者(≥18岁),来自6个国家,主要来源于康复医学、物理和康复医学、神经科学、生物工程医学、作业治疗等研究领域,发表年限集中于2013年以后。纳入文献物理治疗证据数据库(PEDro)量表评分平均7.5分。基于WHO-FICs框架,纳入文献中涉及的疾病类型涵盖脑出血(8B00)、缺血性脑卒中(8B11)、蛛网膜下腔出血(8B01)、肌张力和异常反射(MB47)、偏瘫(MB53)。主要功能障碍包括关节活动功能(b710)、关节稳定性功能(b715)、肌肉力量功能(b730)、肌张力功能(b735)、运动反射功能(b750)、随意运动控制功能(b760)、不随意运动功能(b765)。主要活动受限和参与局限包括上肢的活动和参与,如举起和搬运物体(d430),手和手臂的使用(d445),精巧手的使用(d440);以及日常生活活动和社会参与能力,如自理(d510-d570),家庭生活(d610-d660),主要生活领域(d810-d879),社区、社会和公民生活(d910-d950)。涉及身体功能的治疗类干预措施有肌肉功能电刺激(MU2.SC.BP)、协助和指导运动功能训练(MV2.PG.ZZ);涉及活动和参与的治疗类干预措施有举起和搬运物体训练(SIA.PH.ZZ)、使用精巧手的训练(SIG.PH.ZZ)、使用上肢和手的训练(SIJ.PH.ZZ)、自理的干预措施(SM1-SMH)、主要生活领域的干预措施(SO2-SOD)、游戏训练(SXD.PH.ZZ)。每次干预15~60 min,每周3~10次,持续3~8周。干预场所一般为医院或居家。干预效果分为3个层面:身体功能层面,涉及神经运动传导功能、反射功能、随意运动控制能力、协调性与速度改善,关节活动度和握力增加;活动和参与层面,涉及上肢活动能力和速度、手的精细功能和速度、上肢活动参与的频率和质量,日常生活活动能力提高,参与日常活动任务的困难程度降低;生活质量和福祉层面,涉及获得愉悦感和成就感,生活质量提高。结论基于WHO-FICs构建了作业治疗改善脑卒中上肢功能效果的PICO架构。涉及的疾病类型涵盖脑出血、缺血性脑卒中、蛛网膜下腔出血、肌张力和异常反射以及偏瘫。上肢运动功能障碍主要有随意运动控制功能障碍,运动反射功能减弱或亢进,肌张力异常,肌肉协调障碍,关节活动稳定性差,肌力减退等,活动受限和参与局限性表现为手臂和手的活动参与功能障碍,手的精细活动功能障碍,影响日常生活活动和社会参与能力。涉及身体功能的治疗类干预措施有基于脑机接口的神经肌肉电刺激治疗、单上肢镜像训练;涉及活动和参与的治疗类干预措施有动作观察训练、双上肢镜像训练、任务导向训练、双上肢训练及上肢机器人训练。健康和功能效益主要表现为上肢运动功能、上肢的活动和参与水平、日常生活活动能力和社会参与能力提高,生活质量与福祉改善。 展开更多
关键词 脑卒中 作业治疗 上肢 活动和参与 世界卫生组织国际分类家族 系统综述
下载PDF
WHO流产护理指南(2022)解读
19
作者 钱金凤 王彩燕 姚晓英 《中国计划生育学杂志》 2023年第9期2262-2266,共5页
流产尤其是不安全流产危害女性生殖健康,世界卫生组织全球生殖健康战略将消除不安全流产确定为一项优先任务,并在2022年更新了流产护理指南。本文将指南中有关临床处理及流产后避孕方法使用建议等方面新增或更新的建议做一简单解读。需... 流产尤其是不安全流产危害女性生殖健康,世界卫生组织全球生殖健康战略将消除不安全流产确定为一项优先任务,并在2022年更新了流产护理指南。本文将指南中有关临床处理及流产后避孕方法使用建议等方面新增或更新的建议做一简单解读。需注意指南中的内容与我国相关临床操作指南与技术操作规范以及专家共识的异同,在工作中根据我国国情结合具体情况加以应用,实现安全流产。 展开更多
关键词 世界卫生组织 流产 指南 解读 流产和避孕
下载PDF
World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients 被引量:1
20
作者 Christina N Kontoghiorghe Nicholas Andreou +1 位作者 Katerina Constantinou George J Kontoghiorghes 《World Journal of Methodology》 2014年第3期163-188,共26页
According to global annual estimates hunger/malnutrition is the major cause of death(36 of 62 million). Cardiovascular diseases and cancer(5.44 of 13.43 million) are the major causes of death in developed countries, w... According to global annual estimates hunger/malnutrition is the major cause of death(36 of 62 million). Cardiovascular diseases and cancer(5.44 of 13.43 million) are the major causes of death in developed countries, while lower respiratory tract infections, human immunodeficiency virus infection/acquired immunodeficiency syndrome, diarrhoeal disease, malaria and tuberculosis(10.88 of 27.12 million) are the major causes of death in developing countries with more than 70% of deaths occurring in children. The majority of approximately 800 million people with other rare diseases, including 100000 children born with thalassaemia annually receive no treatment. There are major ethical dilemmas in dealing with global health issues such as poverty and the treatment of orphan and rare diseases. Of approximately 50000 drugs about 10% are orphan drugs, with annual sales of the latter approaching 100 billion USD. In comparison, the annual revenue in 2009 from the top 12 pharmaceutical companies in Western countrieswas 445 billion USD and the top drug, atorvastatin, reached 100 billion USD. In the same year, the total government expenditure for health in the developing countries was 410 billion USD with only 6%-7% having been received as aid from developed countries. Drugs cost the National Health Service in the United Kingdom more than 20 billion USD or 10% of the annual health budget. Uncontrollable drug prices and marketing policies affect global health budgets, clinical practice, patient safety and survival. Fines of 5.3 billion USD were imposed on two pharmaceutical companies in the United States, the regulatory authority in France was replaced and clinicians were charged with bribery in order to overcome recent illegal practises affecting patient care. High expenditure for drug development is mainly related to marketing costs. However, only 2 million USD was spent developing the drug deferiprone(L1) for thalassaemia up to the stage of multicentre clinical trials. The criteria for drug development, price levels and use needs to be readdressed to improve drug safety and minimise costs. New global health policies based on cheaper drugs can help the treatment of many categories of orphan and rare diseases and millions of orphan patients in developing and developed countries. 展开更多
关键词 world health issues Global DISEASES Orphandrugs ORPHAN DISEASES Rare DISEASES ORPHAN PATIENTS THALASSAEMIA DEFERIPRONE DEFERASIROX Deferoxamine Iron overload
下载PDF
上一页 1 2 141 下一页 到第
使用帮助 返回顶部